Journal of the American College of Surgeons
Volume 209, Issue 2 , Pages 180-187 , August 2009

Association of Routine Pretreatment Magnetic Resonance Imaging with Time to Surgery, Mastectomy Rate, and Margin Status

Abstract presented at the American Society of Clinical Oncology Breast Symposium, Washington, DC, September 2008.

  • Richard J. Bleicher, MD, FACS

      Affiliations

    • Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA
    • Corresponding Author InformationCorrespondence address: Richard J Bleicher, MD, Department of Surgical Oncology, Fox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA 19111
    • ,
  • Robin M. Ciocca, DO

      Affiliations

    • Department of Surgery, Lankenau Hospital, Wynnewood, PA
    • ,
  • Brian L. Egleston, PhD

      Affiliations

    • Department of Biostatistics, Fox Chase Cancer Center, Philadelphia, PA
    • ,
  • Linda Sesa, MSN, CRNP, AOCNP

      Affiliations

    • Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA
    • ,
  • Kathryn Evers, MD, FACR

      Affiliations

    • Department of Diagnostic Imaging, Fox Chase Cancer Center, Philadelphia, PA
    • ,
  • Elin R. Sigurdson, MD, PhD, FACS

      Affiliations

    • Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA
    • ,
  • Monica Morrow, MD, FACS

      Affiliations

    • Breast Surgery Service, Memorial Sloan Kettering Cancer Center, New York, NY

Received 3 January 2009 ,Revised 11 April 2009 ,Accepted 14 April 2009.

References 

  1. Esserman L, Hylton N, Yassa L, et al. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol. 1999;17:110–119
  2. Liberman L, Morris EA, Dershaw DD, et al. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol. 2003;180:901–910
  3. Wapnir IL, Anderson SJ, Mamounas EP, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol. 2006;24:2028–2037
  4. Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol. 2008;26:3248–3258
  5. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–2106
  6. Bassett LW, Dhaliwal SG, Eradat J, et al. National trends and practices in breast MRI. AJR Am J Roentgenol. 2008;191:332–339
  7. American Joint Committee on Cancer, American Cancer SocietyGreene FL. AJCC cancer staging manual. New York: Springer-Verlag; 2002;xiv:421
  8. Raghunathan TE, Lepkowski JM, Van Hoewyk J, Solenberger P. A multivariate technique for multiply imputing missing values using a sequence of regression models. Survey Methodol. 2001;27:85–95
  9. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004;351:427–437
  10. Leach MO, Boggis CR, Dixon AK, et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet. 2005;365:1769–1778
  11. Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 2005;23:8469–8476
  12. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75–89
  13. Anderson J, Walker LG, Leach MO. Magnetic resonance imaging: an acceptable way of screening women with a family history of breast cancer. Breast Cancer Res Treat. 2004;88:S188
  14. Plevritis SK, Kurian AW, Sigal BM, et al. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA. 2006;295:2374–2384
  15. ACR practice guideline for the performance of magnetic resonance imaging (MRI) of the breast. http://www.acr.org/secondarymainmenucategories/quality_safety/guidelines/breast/mri_breast.aspxAccessed May 15, 2009
  16. Mann RM, Kuhl CK, Kinkel K, Boetes C. Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol. 2008;18:1307–1318
  17. Consensus statement: The use of magnetic resonance imaging in breast oncology. Newsletter of The American Society of Breast Surgeons. 2005;Winter:7
  18. Katipamula R, Hoskin TL, Boughey JC, et al. Trends in mastectomy rates at the Mayo Clinic Rochester: Effect of surgical year and preoperative MRI. J Clin Oncol. 2008;26:9S
  19. Hollingsworth AB, Stough RG, O'Dell CA, Brekke CE. Breast magnetic resonance imaging for preoperative locoregional staging. Am J Surg. 2008;196:389–397
  20. Lalonde L, David J, Trop I. Magnetic resonance imaging of the breast: current indications. Can Assoc Radiol J. 2005;56:301–308
  21. Grobmyer SR, Mortellaro VE, Marshall J, et al. Is there a role for routine use of MRI in selection of patients for breast-conserving cancer therapy?. J Am Coll Surg. 2008;206:1045–1050discussion 1042–1050
  22. Bedrosian I, Mick R, Orel SG, et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer. 2003;98:468–473
  23. Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233:830–849
  24. Bilimoria KY, Cambic A, Hansen NM, Bethke KP. Evaluating the impact of preoperative breast magnetic resonance imaging on the surgical management of newly diagnosed breast cancers. Arch Surg. 2007;142:441–445discussion 445–447
  25. Deurloo EE, Peterse JL, Rutgers EJ, et al. Additional breast lesions in patients eligible for breast-conserving therapy by MRI: impact on preoperative management and potential benefit of computerised analysis. Eur J Cancer. 2005;41:1393–1401
  26. Tillman GF, Orel SG, Schnall MD, et al. Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. J Clin Oncol. 2002;20:3413–3423
  27. Morrow M, Hamilton AS, Katz SJ. Why do women get mastectomy? (Results from a population-based study). J Clin Oncol. 2007;25:28S
  28. Krishnan M, Thorsteinsson D, Horowitz N, et al. The influence of preoperative MRI in the timing and type of therapy in women newly diagnosed with breast cancer. Am J Roentgenol. 2008;190:A31–A34
  29. Richards MA, Westcombe AM, Love SB, et al. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353:1119–1126
  30. Barber MD, Jack W, Dixon JM. Diagnostic delay in breast cancer. Br J Surg. 2004;91:49–53
  31. Solin LJ, Orel SG, Hwang WT, et al. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol. 2008;26:386–391

 Disclosure Information: Nothing to disclose.

 This work was supported, in part, by US Public Health Services grant 5P30 CA06927 and by an appropriation from the Commonwealth of Pennsylvania.

PII: S1072-7515(09)00409-8

doi: 10.1016/j.jamcollsurg.2009.04.010

Journal of the American College of Surgeons
Volume 209, Issue 2 , Pages 180-187 , August 2009

Article Tools

* Image Usage & Resolution